Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(27%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
55%
Ph phase_2
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting3
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (14.3%)
N/A6 (85.7%)

Trials by Status

completed545%
recruiting327%
unknown218%
not_yet_recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DEVICE
Total Trials
11